Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy. [electronic resource]
Producer: 20020102Description: 471-9 p. digitalISSN:- 1464-8431
- Adenocarcinoma -- immunology
- Animals
- Antibodies, Viral -- immunology
- Antigen Presentation
- Antigens, Neoplasm -- genetics
- Autoimmunity
- B7-1 Antigen -- genetics
- Canarypox virus -- genetics
- Cancer Vaccines -- administration & dosage
- Cell Compartmentation
- Clinical Trials as Topic
- Combined Modality Therapy
- Cytokines -- genetics
- DNA, Recombinant -- genetics
- Fowlpox virus -- genetics
- Genetic Therapy -- methods
- Genetic Vectors -- administration & dosage
- Humans
- Immunotherapy -- methods
- Immunotherapy, Active
- Male
- Mice
- Mice, Transgenic
- Neoplasm Metastasis
- Neoplasm Transplantation
- Poxviridae -- genetics
- Promoter Regions, Genetic -- genetics
- Prostatic Neoplasms -- immunology
- Rats
- Recombinant Fusion Proteins -- immunology
- Salvage Therapy
- Self Tolerance
- Smallpox Vaccine -- immunology
- Species Specificity
- Vaccination
- Vaccinia -- genetics
- Viral Vaccines -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.